Albuterol Sulfate Solution
Product Images NDC 81894-106

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 81894-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Luoxin Aurovitas Pharma (chengdu) Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 % Change From Pre-dose Fev1 Intent-to-treat Population Day 1 (Albuterol Fig1)

Figure 1 % Change From Pre-dose Fev1 Intent-to-treat Population Day 1 (Albuterol Fig1)
This is a chart showing the % change from the pre-dose FEV in an Intent-to-Treat Population. The chart displays data points for different time periods after the pre-dose treatment with albuterol at two different dosages and a placebo. The x-axis represents the hours from the pre-dose, and the y-axis shows the % change values. The chart includes values at various time points up to 400 hours. The data visualization allows for the comparison of the % change in FEV over time between the different treatments.*
FDA Label Image

Carton Label (25 Vials)-1.25 mg/3 mL (Albuterol Fig10)

Carton Label (25 Vials)-1.25 mg/3 mL (Albuterol Fig10)
This text provides information about Albuterol Sulfate Inhalation Solution in unit-dose vials. Each vial contains 1.25 mg of albuterol (equivalent to 1.5 mg of albuterol sulfate) and is intended for inhalation only. The product is sterile and manufactured by Aurobindo Pharma USA, Inc. The carton contains 5 pouches of five 3 mL vials each. Pharmacists are advised to detach the patient's instructions for use from the package insert and dispense with the solution.*
FDA Label Image

Carton Label (30 Vials)-1.25 mg/3 mL (Albuterol Fig11)

Carton Label (30 Vials)-1.25 mg/3 mL (Albuterol Fig11)
This is an information sheet for Albuterol Sulfate Inhalation Solution, with a concentration of 1.25 mg per 3 mL unit dose vial. The product is intended for inhalation use only and is available in sterile unit-dose vials. The package contains 6 pouches, each with five 3 mL vials. The manufacturer is Aurobindo Pharma USA, Inc. located at 279 Princeton Hightstown Road, East Windsor, NJ 08520. The text also includes important instructions for pharmacists regarding dispensing the product.*
FDA Label Image

Figure 2 % Change From Pre-dose Fev1 Intent-to-treat Population Day 28 (Albuterol Fig2)

Figure 2 % Change From Pre-dose Fev1 Intent-to-treat Population Day 28 (Albuterol Fig2)
This text appears to indicate a graph showing the percentage change from pre-dose FEV in the Intent-to-Treat population. The graph includes data for Day 28 with various time points and different treatments such as albuterol 1.25 mg, albuterol 0.63 mg, and placebo. The x-axis likely represents hours from pre-dose, while the y-axis shows the percentage change.*
FDA Label Image

Figure 1 (Albuterol Fig3)

Figure 1 (Albuterol Fig3)
FDA Label Image

Figure 2 (Albuterol Fig4)

Figure 2 (Albuterol Fig4)
FDA Label Image

Figure 3, 4 (Albuterol Fig5)

Figure 3, 4 (Albuterol Fig5)
FDA Label Image

Pouch Label (5 Vials)-0.63 mg/3 mL (Albuterol Fig6)

Pouch Label (5 Vials)-0.63 mg/3 mL (Albuterol Fig6)
This is a description of a medication distributed by Aurobindo Pharma USA, Inc. The product is an inhalation solution containing Albuterol sulfate USP in each 3 mL vial. The inactive ingredients include Sodium chloride, sulfuric acid, and water for injection. The storage instructions advise protecting the solution from light and storing between 2°C to 25°C. Each unit dose vial contains 0.63 mg of albuterol, equivalent to 0.75 mg of albuterol sulfate. The vials should be kept in the protective foil pouch at all times and used within one week after removal from the pouch. It is recommended for inhalation only and for use in children aged 2 to 12 years. The product is in sterile unit-dose vials, and the prescribed dosage should not be exceeded.*
FDA Label Image

Carton Label (25 Vials)-0.63 mg/3 mL (Albuterol Fig7)

Carton Label (25 Vials)-0.63 mg/3 mL (Albuterol Fig7)
This text provides information on an Albuterol Sulfate Inhalation Solution that comes in sterile unit-dose vials containing 0.63 mg of albuterol equivalent to 0.75 mg of albuterol sulfate. The product is intended for inhalation use only and pharmacists are instructed to detach the patient's instructions for use from the package insert before dispensing. The solution is presented in cartons with pouches containing five 3 mL vials each. Manufacturer details from Aurobindo Pharma USA, Inc. are also provided. The NDC (National Drug Code) for this product is 8189410525.*
FDA Label Image

Carton Label (30 Vials)-0.63 mg/3 mL (Albuterol Fig8)

Carton Label (30 Vials)-0.63 mg/3 mL (Albuterol Fig8)
This text is a product label for Albuterol Sulfate Inhalation Solution. The solution is contained in unit dose vials, with each vial containing 0.63 mg of albuterol sulfate. The product is intended for inhalation use only and pharmacist instructions must be followed. The address of the manufacturer is shown as Princton, East Windsor, NJ. Each carton contains 6 pouches of Five 3 mL vials each. The NDC number for the product is 8189410530.*
FDA Label Image

Pouch Label (5 Vials)-1.25 mg/3 mL (Albuterol Fig9)

Pouch Label (5 Vials)-1.25 mg/3 mL (Albuterol Fig9)
This text is a description of Albuterol Sulfate Inhalation Solution, provided in 3mL vials. It contains Albuterol sulfate as the active ingredient and is intended for use in children aged 2 to 12. The storage conditions advise protecting from light and storing between 2°C to 25°C. The vials should be kept in the foil pouch and used within one week after removal. The recommended dosage should not be exceeded, and use should be directed by a physician. The product is distributed by Aurobindo Pharma USA, Inc. and manufactured by Luoxin Aurovitas Pharma in China. Each unit dose vial contains 1.25 mg of albuterol sulfate.*
FDA Label Image

Albuterol-str (Albuterol Str)

Albuterol-str (Albuterol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.